Opportunity Overview
The Vermont Emergency Naloxone Unit Application is an active Vermont Department of Health, Division of Substance Use Programs opportunity intended to increase access to emergency naloxone (Narcan nasal spray) at locations that have experienced an opioid overdose.
Funding / Assistance and Deadline
This is an in-kind naloxone distribution opportunity, not a cash grant. The current official page does not state a dollar award amount, a fixed number of units available to each applicant, or a total program value.
The application is open until all emergency naloxone units are distributed. The Department notes that a waitlist may be implemented depending on application volume so that locations that have experienced an overdose can be prioritized. No fixed closing date, clock time, or time zone is published.
Who Can Apply
The controlling Vermont Department of Health page states that the program is intended for locations that have experienced an opioid overdose. The public program page does not enumerate a complete list of eligible organization types, so applicants should use the official application form to confirm any additional eligibility or site requirements rather than infer broader eligibility.
Program and Application Notes
The Department states that it is finalizing a contract to purchase the units and asks applicants to allow time between application and delivery. Depending on application volume, a waitlist may be used to prioritize locations with overdose experience.
Application Requirements
The current official application requires organization and requester contact information, an authorized organizational signature accepting responsibility for liability, box maintenance, stocking/re-stocking and replacement, and acquisition of naloxone for the box. Applicants must state the number of boxes requested and whether an opioid overdose has occurred at the intended location.
Required uploads include: (1) a site description of two pages or less explaining overdose-prevention readiness, exact physical location(s), accessibility, and confirmation that the box location will keep naloxone within 36-77 degrees Fahrenheit; (2) policies and procedures for maintaining/checking the box and replacing naloxone; and (3) a staff training plan of two pages or less covering overdose recognition/response and replacement of used naloxone doses. The application also asks whether the organization already receives naloxone directly from the Vermont Department of Health and identifies the person responsible for ordering it.
N9+ / QC Healthcare Analysis
Atlas Opportunity Score: 42/100. This is a legitimate, currently open Vermont healthcare and overdose-prevention opportunity, but it provides in-kind naloxone rather than grant funding and has a narrow harm-reduction purpose.
N9+ Fit: 0/100. The Nonagon N9+ remote physical examination platform has no material connection to the stated purpose of distributing emergency naloxone. Atlas should not force N9+ into this opportunity.
QC Healthcare Fit: 5/100. General clinical experience may be contextually relevant to overdose response, but the opportunity is not a physician-services procurement and does not establish a credible QC Healthcare direct-vendor role.
Next Action
Vermont organizations operating a location that has experienced an opioid overdose should review and submit the official application promptly while units remain available. Because the state may establish a waitlist and does not publish a fixed close date, applicants should not delay based on an assumed later deadline.
Official source: Vermont Department of Health — Requests for Proposals, Information and Applications.